MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Cardiac hypertrophy is a major cardiovascular disease complication, often leading to sudden cardiac death.
• The underlying molecular mechanisms of cardiac hypertrophy remain incompletely understood.
• Angiotensin II (Ang II) is a key factor in inducing cardiomyocyte hypertrophy.

Purpose of the Study:

• To elucidate the molecular mechanism of Ang II-induced cardiomyocyte hypertrophy.
• To identify novel molecular targets for treating cardiac hypertrophy and heart failure.

Main Methods:

• Induction of cardiomyocyte hypertrophy using Angiotensin II (Ang II).
• Quantitative analysis of microRNA (miR-27a-3p) and gene expression.
• Luciferase reporter assays to confirm gene regulation.
• Overexpression and inhibition studies of key genes (miR-27a-3p, Hoxa10).
• Assessment of cardiac hypertrophy and electrical remodeling markers.

Main Results:

• Ang II upregulated miR-27a-3p and hypertrophy-related genes.
• Inhibiting miR-27a-3p alleviated cardiac hypertrophy and electrical remodeling.
• miR-27a-3p directly targets and downregulates Hoxa10 expression.
• Hoxa10 overexpression reversed Ang II-induced cardiac hypertrophy and electrical remodeling.
• Hoxa10 positively regulates Kv4.3 potassium channel expression, which is reduced in hypertrophy.

Conclusions:

• The miR-27a-3p/Hoxa10/Kv4.3 axis is a novel mechanism in Ang II-induced cardiomyocyte hypertrophy.
• This pathway represents a potential therapeutic target for cardiac hypertrophy and heart failure.